|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
FY2017
12 months to Dec 31, 2017
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues | |||||
| Gross Profit | |||||
| Operating expenses | |||||
| Sales and marketing | |||||
| General and administrative | |||||
| Research and development | |||||
| Amortization of intangible assets | |||||
| Goodwill impairment | |||||
| Restructuring charges | |||||
| Change in fair value of contingent consideration | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Interest expense, net | |||||
| Loss from repurchase/issuance of shares | |||||
| Change in fair value of warrant liability | |||||
| Gain on extinguishment of debt | |||||
| Other income (loss), net | |||||
| Total other income (expense), net | |||||
| Loss before income taxes | |||||
| Benefit from (Provision for) income taxes | |||||
| Net loss | |||||
| Net loss applicable to common shareholders | |||||
| Net loss per share, basic and diluted | |||||
| Weighted average common shares outstanding, basic and diluted | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted average common shares outstanding, basic | |||||
| Weighted average common shares outstanding, diluted | |||||
| Other comprehensive gain (loss): | |||||
| Foreign currency translation gain (loss) | |||||
| Total other comprehensive gain (loss) | |||||
| Comprehensive loss | |||||
Loading...